Mitochondrial Dysfunction, Insulin Resistance, and Type 2 Diabetes Mellitus

被引:130
作者
Abdul-Ghani, Muhammad A. [1 ]
DeFronzo, Ralph A. [1 ]
机构
[1] Univ Texas Hlth Sci Ctr San Antonio, Diabet Div, San Antonio, TX 78229 USA
关键词
D O I
10.1007/s11892-008-0030-1
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Insulin resistance is a characteristic feature of type 2 diabetes mellitus, obesity, and the metabolic syndrome. Increased intracellular fat content in skeletal muscle and liver associated with insulin resistance has led to the hypothesis that a mitochondrial defect in substrate oxidation exists in disorders of insulin resistance. In vivo measurements of metabolic fluxes through the tricarboxylic acid and oxidative phosphorylation with magnetic resonance spectroscopy have demonstrated multiple defects in mitochondrial function in skeletal muscle. A decrease in mitochondrial density and mitochondrial copy number has been reported in have not been a consistent observation in all studies. Similarly, an intrinsic functional defect in mitochondrial adenosine triphosphate production synthesis has been reported in some but not all studies. This review summarizes evidence that implicates a defect in mitochondrial oxidative phosphorylation and its relationship to insulin resistance in common metabolic diseases characterized by impaired insulin action.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 67 条
[1]
Abdul-Ghani MA, 2007, DIABETES, V56, pA337
[2]
ABDULGHANI MA, 2008, DIABETES S1, V56, pA1456
[3]
Ceramide content is increased in skeletal muscle from obese insulin-resistant humans [J].
Adams, JM ;
Pratipanawatr, T ;
Berria, R ;
Wang, E ;
DeFronzo, RA ;
Sullards, MC ;
Mandarino, LJ .
DIABETES, 2004, 53 (01) :25-31
[4]
Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia [J].
Asmann, Yan W. ;
Stump, Craig S. ;
Short, Kevin R. ;
Coenen-Schimke, Jill M. ;
Guo, ZengKui ;
Bigelow, Maureen L. ;
Nair, K. Sreekumaran .
DIABETES, 2006, 55 (12) :3309-3319
[5]
Metabolic and molecular basis of insulin resistance [J].
Bajaj, M ;
DeFronzo, RA .
JOURNAL OF NUCLEAR CARDIOLOGY, 2003, 10 (03) :311-323
[6]
Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty acyl-CoAs and insulin action in type 2 diabetic patients [J].
Bajaj, M ;
Suraamornkul, S ;
Romanelli, A ;
Cline, GW ;
Mandarino, LJ ;
Shulman, GI ;
DeFronzo, RA .
DIABETES, 2005, 54 (11) :3148-3153
[7]
Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: Peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach [J].
Bays, H ;
Mandarino, L ;
DeFronzo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) :463-478
[8]
Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients [J].
Befroy, Douglas E. ;
Petersen, Kitt Falk ;
Dufour, Sylvie ;
Mason, Graeme F. ;
de Graaf, Robin A. ;
Rothman, Douglas L. ;
Shulman, Gerald I. .
DIABETES, 2007, 56 (05) :1376-1381
[9]
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis [J].
Belfort, Renata ;
Harrison, Stephen A. ;
Brown, Kenneth ;
Darland, Celia ;
Finch, Joan ;
Hardies, Jean ;
Balas, Bogdan ;
Gastaldelli, Amalia ;
Tio, Fermin ;
Pulcini, Joseph ;
Berria, Rachele ;
Ma, Jennie Z. ;
Dwivedi, Sunil ;
Havranek, Russell ;
Fincke, Chris ;
DeFronzo, Ralph ;
Bannayan, George A. ;
Schenker, Steven ;
Cusi, Kenneth .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2297-2307
[10]
BENTON CR, 2007, J BIOL CHEM